
Talis Biomedical Investor Relations Material
Latest events

Q2 2023
Talis Biomedical

Q2 2024
18 Aug, 2024

Q1 2024
8 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Talis Biomedical Corp
Access all reports
Talis Biomedical Corp is a molecular diagnostic company focused on health and patient outcomes through the development and delivery of accurate infectious disease testing at the point of care. The company's efforts are concentrated on diagnosing infectious diseases rapidly, accurately, and directly at the point-of-care. Their product development includes the Talis One system, designed to overcome the limitations of existing point-of-care diagnostic testing technologies, with applications in respiratory infections, women's health infections, sexually transmitted infections, and more. The company is headquartered in Redwood City, California and its shares are listed on the Nasdaq.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
TLIS
Country
🇺🇸 United States